Replacement of Nebulised Ipratropium With Inhaled Tiotropium in Stable COPD [chronic obstructive pulmonary disease].
Withdrawn prior to enrolment
Phase of Trial: Phase IV
Latest Information Update: 27 Jul 2010
At a glance
- Drugs Tiotropium bromide (Primary) ; Ipratropium bromide
- Indications Chronic obstructive pulmonary disease
- Focus Therapeutic Use
- 27 Jul 2010 Status changed from not yet recruiting to withdrawn prior to recruitment as reported by ClinicalTrials.gov.
- 01 Oct 2006 New trial record.